Øyvind H.
- Country
- Norway
- Department
- Kreftavdelingen UNN
Research Overview
Data & Insights
Has run more than one trial at 0 of 26 partner sites.
Specializations
Solid Tumor Oncology
The investigator concentrates on innovative therapeutic approaches for a broad spectrum of solid malignancies, integrating targeted therapies and immunomodulatory agents.
- Breast cancer
- Colorectal cancer
- Non‑small cell lung cancer
- Ovarian cancer
- Prostate cancer
- Endometrial cancer
- Gastric cancer
- Head and neck cancer
- Cutaneous malignant melanoma
- Hepatocellular carcinoma
Research emphasizes combination regimens that enhance efficacy while addressing disease heterogeneity.
Hematologic Malignancies
His work targets blood‑derived cancers, exploring novel agents and conditioning strategies to improve remission durability.
- Acute lymphoblastic leukaemia
- Acute myeloid leukemia
- Myelodysplastic syndrome
- Multiple myeloma
- Follicular lymphoma
- Mantle cell lymphoma
- High‑risk medulloblastoma
- Hematologic acute leukemias in pediatric populations
- Chronic lymphocytic leukemia
- Refractory B‑cell lymphomas
Focus includes integration of immunotherapies and precision‑medicine biomarkers to guide treatment selection.
Immune‑Mediated and Inflammatory Disorders
The investigator is active in chronic inflammatory conditions, evaluating biologic and small‑molecule therapies to achieve sustained disease control.
- Crohn’s disease
- Ulcerative colitis
- Psoriasis
- Rheumatoid arthritis
- Juvenile idiopathic arthritis
- Eosinophilic esophagitis
- Hidradenitis suppurativa
- Systemic lupus erythematosus
- Polymyalgia rheumatica
- Immune thrombocytopenia
Research aims to balance efficacy with safety, particularly in pediatric and adult populations with refractory disease.
Neurological and Neurodegenerative Diseases
His clinical interests extend to disorders of the central nervous system, focusing on disease‑modifying interventions and symptom management.
- Alzheimer’s disease
- Amyotrophic lateral sclerosis
- Multiple sclerosis
- Dementia with Lewy bodies
- Mild cognitive impairment
- Neurodegenerative leukodystrophies
- Parkinsonian syndromes
- Neuroregenerative stem‑cell approaches
- Stroke recovery therapies
- Severe migraine and cluster headache
Efforts prioritize translational strategies that may alter disease trajectory.
Cardiovascular, Renal and Metabolic Conditions
He contributes to studies addressing vascular disease, arrhythmia‑related stroke prevention, and kidney dysfunction, often in high‑risk cohorts.
- Atherosclerotic cardiovascular disease
- Atrial fibrillation
- Chronic kidney disease
- Proteinuric kidney diseases
- Stroke prophylaxis
- Coronary artery disease
- Metabolic dysfunction‑associated steatotic liver disease
- Hypertension management
- Antiplatelet therapy optimization
- Cardiovascular outcome reduction with novel lipid‑lowering agents
Investigations often explore anticoagulation and antiplatelet strategies tailored to renal impairment and arrhythmic risk.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.